Lazard Asset Management
KROS icon

Lazard Asset Management’s Keros Therapeutics KROS Stock Holding History

Lazard Asset Management’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$291K Buy
+21,849
New +$291K ﹤0.01% 1626
2022
Q2 		– Sell
-1,237
Closed -$67K – 2480
2022
Q1 		$67K Buy
+1,237
New +$67K ﹤0.01% 1587